The drug mimics GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production
While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations
Carrageenan has been proven safe for human consumption
Initially, GLP-1 drugs were developed and approved to lower blood sugar and A1C levels in patients with type 2 diabetes
He says about 15% of all diabetes patients fall into a category known as severe insulin deficiency. Those patients fail to make much insulin to begin with, most likely needing a pump or injections down the line
This case report aimed to uncover potential adverse effects of a GLP1 agonist generalized as one of the anti-addiction compounds [1]